News for GeneMatrix Inc. (109820.KQ)

Published at

Feb 11, 2022 9:45 PM

by prnewswire.com

mixed

mixed

COVID-19 Nucleic Acid Amplification Tests (NAATs) Medical Devices Pipeline Market Report 2021: Analysis by Stage of Development, Territory, Regulatory Path, Estimated Approval Date, Clinical Trials

/PRNewswire/ -- The "COVID-19 Nucleic Acid Amplification Tests (NAATs) - Medical Devices Pipeline Product Landscape, 2021" report has been added to...

AVCO APDN TMO.MX TMO THMO PMCBD PMCB PKI P1KI34.SA OBD.L GNMK FLGT.MX FLGT ERRFY ERFSF ERFNV.PA ERF.PA ENZ CODX 603313.SS 214610.KQ 137310.KS 109820.KQ 0R0H.L 0KHE.L 0IUT.L 0IHV.L 0A50.L 096530.KQ 084650.KQ 048530.KQ 038290.KQ FBSBF 2INV.DE

Read more →
Published at

Oct 12, 2021 10:00 AM

by prnewswire.com

positive

positive

NeoPlex (TM) HPV29 Detection, a new molecular detection kit from Genematrix, acquires European CE-IVD certification

/PRNewswire/ -- Genematrix (KRX 109820), specialized in real-time PCR based molecular diagnostics, announced that 'NeoPlex™ HPV29 Detection', which can...

109820.KQ

Read more →